Speakers

Albert DeRitis

Assistant Clinical Professor, Accounting

Drexel University

Amar Gandhi

Principal, Technology Consulting

Crowe LLP

Andrea Willette, CPA

Professional Accounting Fellow

U.S. Securities and Exchange Commission

Andreas Chrysostomou

Managing Director, Valuation Services, Global Healthcare & Life Sciences Industry Leader

Kroll

Anna Simansky

Vice President, Global Audit Services

Zimmer Biomet

Blaise Coleman

Board Member/Audit Committee Chair

Ocugen

Brett Nussbaum

Head of Gross to Net Accounting

Novartis

Christian Alaia

Senior Director, FP&A

Immuneering Corporation

Christian Nodgaard

Senior Manager of Risk Management

Baker Tilly

Dana Hughes

Principal, Advisory, Transaction Strategy

KPMG

Darren Jones

Principal

Baker Tilly

David Nadell

Managing Director, Strategic Value Advisory

Kroll

Dayna Hamel

Lead Solutions Consultant

Workiva

Deglan Reager

Director, Technical Accounting

Gilead Sciences

Donna Heffner

Biopharma Executive | Value Chain, Operations & Enterprise Strategy

Independent; Former Vice President, GPS Strategy & Business Intelligence, Bristol Myers Squibb

Doreen Levine

Partner, Americas Financial Accounting Advisory Services Health Sciences Leader

Ernst & Young

Eric Benson

Senior Manager

Deloitte & Touche LLP

Erica Vandell-DeMarco, CPA

Managing Director

The Siegfried Group, LLP

Erin Warner Guill

President and Chief Operating Officer

Auxilius

Ethan Holdaway

Vice President, Strategic Finance & IR

ProKidney

Frank Panaro

Director, Finance Valuation and Business Case Modeling

Bayer

Gina Tracey

Vice President, Corporate Controller

Alnylam Pharmaceuticals

Grant Kluesner

Senior Manager

Deloitte & Touche LLP

Hikmete O'Brien

Controller

Laxxon Medical

Jeff Clayton

Principal

Baker Tilly

Jeffrey Miller

Vice President, Finance & Corporate Controller

Lannett Company

Jenni Humes

Chief Accounting Officer

Roivant

Jennifer Kyle

Founder and CEO

Condor Software

Jessica Kahl-Winter

Vice President - Global Audit & Assurance

Johnson & Johnson

Jim Chopas

Chief Accounting Officer

Apellis Pharmaceuticals

Jonathan Goldblatt

Managing Director, Valuation Advisory Services

Kroll

Jonathan Wiles

Manager, Advisory

KPMG

Joseph Metzinger

Vice President, Chief Accounting Officer

Dynavax Technologies

Jovita Nwosu

Director, Accounting Standards

Merck

Katy Rossino

Partner

Deloitte & Touche LLP

Kevin MacKay

Vice President, Global Technical Accounting Advisory Services & Policy

Pfizer

Kevin Nee

Vice President, Finance

Collegium Pharmaceutical

Kit Thorpe

Managing Partner

CFGI

Kristen Godsoe

Audit Principal, New England Life Science Industry Leader

Baker Tilly

Laura Klein

Director, Consolidations and Financial Reporting

Bristol Myers Squibb

Lee Van Horn

Audit Partner

Ernst & Young

Lindsi Scanlan

Partner

CrossCountry Consulting

Mallory Morales

Senior Vice President Finance, Chief Accounting Officer, Treasurer

Immuneering Corporation

Marc Siegel

Former Board Member

FASB and SASB

Maria Beletsky

Vice President, Global Internal Controls

Fresenius Medical Care

Maricel Apuli

Chief Accounting Officer

BridgeBio

Matthew Busch

Vice President of Finance, Chief Accounting Officer

Amgen

Matthew Rickert

Director, Sustainability Controller

Solventum Corporation

Meagan Caldwell

Senior Director of Technical Accounting

Sumitomo Pharma America, Inc

Melissa Leonard

Senior Vice President and Corporate Treasurer

Merck

Michael Buchanio

Managing Director | Deal Advisory & Strategy

KPMG

Michael Clark

Corporate Controller, Executive Director

BeOne Medicines USA, Inc.

Michael Kirk

Senior Manager

Deloitte & Touche LLP

Michelle Buturla, CPA

Senior Director - Finance & Accounting

Treeline Biosciences

Mikkel Beck

Head of HR Services, America

Novo Nordisk

Nathan Knies

Director, Sustainability Controller

Eli Lilly & Co.

Neeraj Kumar

Executive Director, General Management and Strategy Finance, Cardiovascular Metabolism and Neuroscience

Novartis

Nellie Debbeler

Deputy Technical Director

Financial Accounting Standards Board (FASB)

Nick Cernese

Principal, Americas Healthcare & Life Sciences Finance Transformation Leader

Ernst & Young

Nicole Lemerond

Board Director, Audit Committee Member

MediciNova, Inc.

Patrick Coyle

Managing Director - GTN Risk Advisory

Baker Tilly

Paula George

Director, Assistant Controller

Immuneering Corporation

Pranjal Vir

Managing Director

Ernst & Young

Prashanth Brindavan

Partner, Consulting

KPMG

Rakhi Kumar

Board Member/Audit Committee Chair

Neuropace

Rene Salas

Board Member/Financial Expert

ADMA Biologics, Inc.

Robert Auslander

Vice President, Head of Internal Audit

Bausch & Lomb

Robin Kramer

Executive Vice President and Chief Financial Officer

Biogen

Salvatore Giovine

Chief Financial Officer, North America Innovative Medicine

Johnson and Johnson

Sarah Stiff

ESG Controller

Legend Biotech

Scott Godsoe

Executive Director, Assistant Corporate Controller

Vertex Pharmaceuticals

Sean Godbout

Chief Accounting Officer, Global Controller

Biogen

Stephen Rivera

Former Vice President, Global Technical Accounting Advisory Services & Policy

Johnson & Johnson

Stephen Sebastian

Executive Director, Corporate Controller

Immuneering Corporation

T.J. Sharpe

Patient Engagement Expert

Sharpe Patient Insights

Tal Goldhamer

CEO

Find the Tailwind, Former Chief Learning Officer, EY

Ted Huizenga

Senior Vice President, Chief Accounting Officer

Ultragenyx Pharmaceutical

Thomas Cunningham

Associate Vice President, Corporate Accounting and External Reporting

Merck

Thomas Spoerel

Senior Vice President, Chief Finance Officer Regions and Acquisition Integration

Becton Dickinson

Timothy Kocses

Executive Director, US Commercial Controller

Bristol Myers Squibb

Trevor Ackerman

Vice President, Global Tax

Amneal Pharmaceuticals LLC

Tyler Mead

Senior Manager, Financial Reporting and Internal Controls

Immuneering Corporation

Tyler Tedesco

Tax Partner

Crowe LLP